Will therapy with psychadelic drugs become mainstream?

<p>Could psilocybin, the active ingredient in magic mushrooms, play a role in the treatment of PTSD, OCD and eating disorders? </p><br><p>A global series of trials, including one in Tallaght, may add to the evidence that psilocybin can play a unique role in therapy.</p><br><p>Patrick Freyne talks to Conor Pope about the potential of psychedelic therapy and how decades of research were lost to the "war on drugs". </p><br><p><br></p><p><br></p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>